<VariationArchive RecordType="classified" VariationID="102437" VariationName="NM_017775.4(TTC19):c.601_604del (p.Gly201fs)" VariationType="Deletion" Accession="VCV000102437" Version="2" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2022-04-25" DateCreated="2015-05-08" MostRecentSubmission="2015-11-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="108179" VariationID="102437">
      <GeneList>
        <Gene Symbol="TTC19" FullName="tetratricopeptide repeat domain 19" GeneID="54902" HGNC_ID="HGNC:26006" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17p12</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="15999824" stop="16045015" display_start="15999824" display_stop="16045015" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="15902693" stop="15932722" display_start="15902693" display_stop="15932722" Strand="+" />
          </Location>
          <OMIM>613814</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_017775.4(TTC19):c.601_604del (p.Gly201fs)</Name>
      <CanonicalSPDI>NC_000017.11:16006489:GCTGGCT:GCT</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17p12</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="16006490" stop="16006493" display_start="16006490" display_stop="16006493" variantLength="4" positionVCF="16006489" referenceAlleleVCF="TGCTG" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="15909804" stop="15909807" display_start="15909804" display_stop="15909807" variantLength="4" positionVCF="15909803" referenceAlleleVCF="TGCTG" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>G201fs</ProteinChange>
      <ProteinChange>G94fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.15909807_15909810del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.15909807_15909810del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.16006493_16006496del" Assembly="GRCh38">
            <Expression>NC_000017.11:g.16006493_16006496del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_029806.1" sequenceAccession="NG_029806" sequenceVersion="1" change="g.12114_12117del">
            <Expression>NG_029806.1:g.12114_12117del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001271420.2" sequenceAccession="NM_001271420" sequenceVersion="2" change="c.280_283del">
            <Expression>NM_001271420.2:c.280_283del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001258349.1" sequenceAccession="NP_001258349" sequenceVersion="1" change="p.Gly94fs">
            <Expression>NP_001258349.1:p.Gly94fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_017775.4" sequenceAccession="NM_017775" sequenceVersion="4" change="c.601_604del" MANESelect="true">
            <Expression>NM_017775.4:c.601_604del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_060245.3" sequenceAccession="NP_060245" sequenceVersion="3" change="p.Gly201fs">
            <Expression>NP_060245.3:p.Gly201fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA150754" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="613814.0003" DB="OMIM" />
        <XRef Type="rs" ID="794726691" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff reviewed the sequence information reported in PubMed 23532514 Fig. 1C to determine the location of this allele on the current reference sequence. </Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_017775.4(TTC19):c.601_604del (p.Gly201fs) AND Mitochondrial complex III deficiency nuclear type 2" Accession="RCV000088675" Version="3">
        <ClassifiedConditionList TraitSetID="9467">
          <ClassifiedCondition DB="MedGen" ID="C3554605">Mitochondrial complex III deficiency nuclear type 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2013-05-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_017775.4(TTC19):c.601_604del (p.Gly201fs) AND not provided" Accession="RCV000201515" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="CN517202">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-11-02" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2017-11-02" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2015-05-08" MostRecentSubmission="2015-11-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">23532514</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9467" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="17714" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Mitochondrial complex III deficiency nuclear type 2</ElementValue>
                <XRef ID="MONDO:0014063" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MC3DN2</ElementValue>
                <XRef Type="MIM" ID="615157" DB="OMIM" />
              </Symbol>
              <XRef ID="C3554605" DB="MedGen" />
              <XRef ID="MONDO:0014063" DB="MONDO" />
              <XRef Type="MIM" ID="615157" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Developmental Genetics Unit, King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="CN517202" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="213848" SubmissionDate="2015-05-05" DateLastUpdated="2015-05-08" DateCreated="2014-03-20">
        <ClinVarSubmissionID localKey="613814.0003_MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2" title="TTC19, 4-BP DEL, 963TGGC  _MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2" />
        <ClinVarAccession Accession="SCV000121597" DateUpdated="2015-05-08" DateCreated="2014-03-20" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2013-05-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 4 sibs, born of Portuguese parents who were likely related, with mitochondrial complex III deficiency nuclear type 2 (MC3DN2; 615157), Nogueira et al. (2013) identified a homozygous 4-bp deletion (c.963_966delTGGC), predicted to result in a frameshift and premature termination (Ala321AlafsTer8) lacking about 35% of the C terminus. The mutation segregated with the disorder in the family and was not found in 300 ethnically matched controls. Western blot analysis did not detect the TTC19 protein in patient muscle or fibroblasts, and complex III was decreased in muscle from 1 patient. ATP production was not decreased in skin fibroblasts, although there was an increase in the production of reactive oxygen species. The patients had onset between ages 12 and 34 years of a progressive neurodegenerative disorder, resulting in death in 3 patients between ages 30 and 49 years. All presented with severe psychiatric signs, such as compulsive lying, obsessive-compulsive behavior, aggression, avoidance, and hallucinations. The patients developed gait ataxia, dysarthria, dysmetria, and muscle weakness, consistent with cerebellar disease, as well as pyramidal signs and spastic paraparesis later in the disease course. Brain MRI showed olivopontocerebellar atrophy and abnormal signals in the putamen, caudate, and brainstem on T2-weighted imaging. Muscle biopsy in all patients showed a marked reduction of mitochondrial complex III activity to about 33% of control values, and muscle biopsy of 1 patient showed decreased mtDNA copy number (about 45% of controls).</Attribute>
              <Citation>
                <ID Source="PubMed">23532514</ID>
              </Citation>
              <XRef DB="OMIM" ID="615157" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TTC19" />
          </GeneList>
          <Name>TTC19, 4-BP DEL, 963TGGC</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">4-BP DEL, 963TGGC</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="613814.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="478319" SubmissionDate="2019-01-29" DateLastUpdated="2015-11-09" DateCreated="2015-11-09">
        <ClinVarSubmissionID localKey="GDX:64296|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000256228" DateUpdated="2015-11-09" DateCreated="2015-11-09" Type="SCV" Version="2" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-11-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.601_604delGGCT variant in the TTC19 gene has been reported previously in the homozygous and heterozygous states with a second TTC19 variant in association with mitochondrial complex III deficiency; note that c.601_604delGGCT has been reported using alternate nomenclature c.963_966delTGGC and c.964_967delGGCT (Nogueira et al., 2013; Atwal, 2014). The c.601_604delGGCT variant causes a frameshift starting with codon Glycine 201, changes this amino acid to a Methionine residue, and creates a premature Stop codon at position 8 of the new reading frame, denoted p.Gly201MetfsX8. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The c.601_604delGGCT variant is not observed in large population cohorts (Lek et al., 2016). We interpret c.601_604delGGCT as a pathogenic variant.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TTC19" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_017775.3:c.601_604delGGCT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="213848" TraitType="Disease" MappingType="Name" MappingValue="MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2" MappingRef="Preferred">
        <MedGen CUI="C3554605" Name="Mitochondrial complex III deficiency nuclear type 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="478319" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="CN517202" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

